List of Tables
    Table 1. Anti-Parkinson Drugs Market Opportunities & Trends in Global Market
    Table 2. Anti-Parkinson Drugs Market Drivers in Global Market
    Table 3. Anti-Parkinson Drugs Market Restraints in Global Market
    Table 4. Key Players of Anti-Parkinson Drugs in Global Market
    Table 5. Top Anti-Parkinson Drugs Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Anti-Parkinson Drugs Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Anti-Parkinson Drugs Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Anti-Parkinson Drugs Product Type
    Table 9. List of Global Tier 1 Anti-Parkinson Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Anti-Parkinson Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Anti-Parkinson Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Anti-Parkinson Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Anti-Parkinson Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Anti-Parkinson Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Anti-Parkinson Drugs Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Anti-Parkinson Drugs Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Anti-Parkinson Drugs Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Anti-Parkinson Drugs Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Anti-Parkinson Drugs Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Anti-Parkinson Drugs Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Anti-Parkinson Drugs Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Anti-Parkinson Drugs Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Anti-Parkinson Drugs Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Anti-Parkinson Drugs Revenue, (US$, Mn), 2023-2028
    Table 30. AbbVie Corporate Summary
    Table 31. AbbVie Anti-Parkinson Drugs Product Offerings
    Table 32. AbbVie Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 33. Mylan Laboratories Corporate Summary
    Table 34. Mylan Laboratories Anti-Parkinson Drugs Product Offerings
    Table 35. Mylan Laboratories Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 36. Valeant Pharmaceuticals Corporate Summary
    Table 37. Valeant Pharmaceuticals Anti-Parkinson Drugs Product Offerings
    Table 38. Valeant Pharmaceuticals Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 39. Novartis Corporate Summary
    Table 40. Novartis Anti-Parkinson Drugs Product Offerings
    Table 41. Novartis Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 42. GlaxoSmithKline Corporate Summary
    Table 43. GlaxoSmithKline Anti-Parkinson Drugs Product Offerings
    Table 44. GlaxoSmithKline Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 45. Zambon Pharmaceuticals Corporate Summary
    Table 46. Zambon Pharmaceuticals Anti-Parkinson Drugs Product Offerings
    Table 47. Zambon Pharmaceuticals Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 48. Pfizer, Inc. Corporate Summary
    Table 49. Pfizer, Inc. Anti-Parkinson Drugs Product Offerings
    Table 50. Pfizer, Inc. Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 51. Hoffmann-La Roche Corporate Summary
    Table 52. Hoffmann-La Roche Anti-Parkinson Drugs Product Offerings
    Table 53. Hoffmann-La Roche Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 54. Merck & Co. Corporate Summary
    Table 55. Merck & Co. Anti-Parkinson Drugs Product Offerings
    Table 56. Merck & Co. Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 57. Orion Pharma Corporate Summary
    Table 58. Orion Pharma Anti-Parkinson Drugs Product Offerings
    Table 59. Orion Pharma Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 60. UCB Corporate Summary
    Table 61. UCB Anti-Parkinson Drugs Product Offerings
    Table 62. UCB Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 63. Teva Pharmaceutical Industries Ltd. Corporate Summary
    Table 64. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Product Offerings
    Table 65. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 66. Vertical Pharmaceuticals, LLC Corporate Summary
    Table 67. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Product Offerings
    Table 68. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
    Table 69. ACADIA Pharmaceuticals Inc. Corporate Summary
    Table 70. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Product Offerings
    Table 71. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Anti-Parkinson Drugs Segment by Type in 2021
    Figure 2. Anti-Parkinson Drugs Segment by Application in 2021
    Figure 3. Global Anti-Parkinson Drugs Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Anti-Parkinson Drugs Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Anti-Parkinson Drugs Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Anti-Parkinson Drugs Revenue in 2021
    Figure 8. By Type - Global Anti-Parkinson Drugs Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Anti-Parkinson Drugs Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Anti-Parkinson Drugs Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Anti-Parkinson Drugs Revenue Market Share, 2017-2028
    Figure 12. US Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Anti-Parkinson Drugs Revenue Market Share, 2017-2028
    Figure 16. Germany Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 17. France Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Anti-Parkinson Drugs Revenue Market Share, 2017-2028
    Figure 24. China Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 28. India Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Anti-Parkinson Drugs Revenue Market Share, 2017-2028
    Figure 30. Brazil Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Anti-Parkinson Drugs Revenue Market Share, 2017-2028
    Figure 33. Turkey Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Anti-Parkinson Drugs Revenue, (US$, Mn), 2017-2028
    Figure 37. AbbVie Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Mylan Laboratories Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Valeant Pharmaceuticals Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Novartis Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. GlaxoSmithKline Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Zambon Pharmaceuticals Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Pfizer, Inc. Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Hoffmann-La Roche Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Merck & Co. Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Orion Pharma Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. UCB Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 50. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)